CDK4 and colorectal carcinoma: As shown in Figure 1H, the combination of MEK inhibitor and CDK4/6 inhibitor was more effective in limiting colony formation and cell growth than MEK inhibitor monotherapy in the majority of the 11 KRAS mutant CRC cell lines assayed.